« Return to News | CROs/Service Providers

Quintiles opens European headquarters in UK

Wednesday, October 12, 2011 10:42 AM

Quintiles has officially opened its new European headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

Lord Howe, Parliamentary Under-Secretary of State for Health commented: "Having Quintiles open their European headquarters in Reading is excellent news. Their decision shows that the UK is an attractive environment for international pharmaceutical companies to invest in.”

“The Government is committed to promoting the development of new, innovative treatments for NHS patients and I look forward to seeing the results of the exciting work that Quintiles will carry out at Reading,” said Howe.

Quintiles founder, chairman and chief executive Officer Dennis Gillings, CBE, stressed the continued importance of Europe, particularly the UK, in the global market, and Quintiles’ investment in innovation and quality across the spectrum of drug development and commercialization.

Gillings said: “I am proud to extend our strategic commitment to Europe, Middle East and Africa with this regional headquarters investment.  With such a wealth of scientific, medical and commercial expertise in the UK, the move has encouraged more cross-discipline collaboration to better serve Quintiles’ customers and power them forward in the fast-morphing world of biopharma.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.